Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Scarring alopecia affects different hair follicle stem cells than nonscarring alopecia, and the infundibular region could be a new treatment target.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

New treatments for hair loss include low-dose oral minoxidil, light therapy, and innovative therapies targeting hair growth mechanisms.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

Targeting blood vessels may help treat skin diseases.

Targeting DNA methylation can help treat skin disorders and cancers.

Genetic differences affect COVID-19 severity and treatment development.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Targeting Vδ1+T-cells may help treat alopecia areata.

Targeting macrophages may improve wound healing.

Targeting endolysosomes may help treat COVID-19.

Targeting THY1 can improve skin repair and healing.

Targeting specific molecular pathways may improve treatments for chemoresistant cancers.

Smart nano-PROTACs improve cancer treatment by targeting proteins more precisely and reducing side effects.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Targeting multiple pathways may improve treatments for androgenetic alopecia.